State TN
Clinical Trials in Tennessee
Recruiting clinical trials with at least one study location in Tennessee. Data updated daily from ClinicalTrials.gov.
Top Conditions in Tennessee
NCT07193511 Phase 1, Phase 2
Recruiting
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Pati...
Condition
Solid Tumor Cancer
Enrollment
355 pts
Location
United States
Sponsor
Avenzo Therapeutics, Inc.
NCT04634552 Phase 2
Recruiting
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myel...
Condition
Hematological Malignancies
Enrollment
510 pts
Location
United States, Belgium, China
Sponsor
Janssen Research & Development
NCT06188702 Phase 1, Phase 2
Recruiting
S095035 as a Single Agent and in Combination in Adult Participants With Advanced...
Condition
MTAP-deleted Solid Tumors
Enrollment
342 pts
Location
United States, Australia, Denmark
Sponsor
Servier Bio-Innovation LLC
NCT04665739 Phase 2
Recruiting
Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive...
Condition
Advanced Lung Neuroendocrine Tumor
Enrollment
70 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT03723928 N/A
Recruiting
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Re...
Condition
Anatomic Stage IV Breast Cancer AJCC v8
Enrollment
739 pts
Location
United States, Guam, Puerto Rico
Sponsor
SWOG Cancer Research Network
NCT06659055 N/A
Recruiting
Bone Mineral Density Agreement Study Between EOSedge™ Versus Traditional DXA
Condition
Healthy
Enrollment
214 pts
Location
United States
Sponsor
Alphatec Spine, Inc.
NCT06819891 Phase 3
Recruiting
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (...
Condition
Moderately to Severely Active Crohns Disease
Enrollment
425 pts
Location
United States, Argentina, Australia
Sponsor
Hoffmann-La Roche
NCT06872125 Phase 3
Recruiting
A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevu...
Condition
Dravet Syndrome
Enrollment
170 pts
Location
United States, Japan, United Kingdom
Sponsor
Stoke Therapeutics, Inc
NCT05462106 Phase 1, Phase 2
Recruiting
A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down S...
Condition
Amyloid Plaque
Enrollment
176 pts
Location
United States, Spain, United Kingdom
Sponsor
AC Immune SA
NCT05376891 N/A
Recruiting
Met Non Small Cell Cancer Registry (MOMENT)
Condition
Cancer
Enrollment
700 pts
Location
United States, Austria, Belgium
Sponsor
EMD Serono Research & Developm
NCT06345690 N/A
Recruiting
VIA Disc NP Registry 3.0
Condition
Discogenic Pain
Enrollment
500 pts
Location
United States
Sponsor
VIVEX Biologics, Inc.
NCT05079282 Phase 1
Recruiting
Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma
Condition
Relapsed or Refractory T Cell Lymphoma
Enrollment
217 pts
Location
United States
Sponsor
Ono Pharmaceutical Co. Ltd
NCT07288203 Phase 2
Recruiting
A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced M...
Condition
Melanoma (Skin Cancer)
Enrollment
100 pts
Location
United States, Australia, Canada
Sponsor
Iovance Biotherapeutics, Inc.
NCT07285213 Phase 2
Recruiting
Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Ant...
Condition
Clostridioides Difficile Infection
Enrollment
230 pts
Location
United States, Australia, Canada
Sponsor
AstraZeneca
NCT05918861 Phase 3
Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Rece...
Condition
Acute Coronary Syndrome
Enrollment
2,000 pts
Location
United States, Canada, Puerto Rico
Sponsor
DalCor Pharmaceuticals
NCT06498635 Phase 3
Recruiting
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After ...
Condition
Lung Non-Small Cell Carcinoma
Enrollment
306 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06132503 Phase 1
Recruiting
Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With...
Condition
Relapsed or Refractory Lymphomas
Enrollment
110 pts
Location
United States
Sponsor
Lantern Pharma Inc.
NCT05288790 Phase 2
Recruiting
Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT
Condition
Microtia
Enrollment
250 pts
Location
United States
Sponsor
Vanderbilt University Medical
NCT06225596 Phase 2, Phase 3
Recruiting
Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial ...
Condition
Metastatic Urothelial Cancer
Enrollment
956 pts
Location
United States, Argentina, Australia
Sponsor
BicycleTx Limited
NCT03435796 Phase 2, Phase 3
Recruiting
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Condition
Neoplasms
Enrollment
1,541 pts
Location
United States, Australia, Austria
Sponsor
Celgene
NCT06541262 Phase 1, Phase 2
Recruiting
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory...
Condition
Neuroblastoma
Enrollment
104 pts
Location
United States, Canada
Sponsor
Milton S. Hershey Medical Cent
NCT03907046 Phase 3
Recruiting
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Condition
Intracerebral Hemorrhage
Enrollment
700 pts
Location
United States
Sponsor
Yale University
NCT07215312 Phase 2
Recruiting
A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated Wit...
Condition
Diabetes Mellitus, Type 2
Enrollment
100 pts
Location
United States, Argentina
Sponsor
Eli Lilly and Company
NCT06961370 Phase 1
Recruiting
A Study to Investigate Safety, Tolerability, Pharmacokinetics (PK), Pharmacodyna...
Condition
Geographic Atrophy
Enrollment
132 pts
Location
United States
Sponsor
Hoffmann-La Roche
NCT06317662 Phase 2
Recruiting
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer I...
Condition
Acute Leukemia of Ambiguous Lineage
Enrollment
153 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI